Athenahealth (Nasdaq: ATHN ) is expected to report Q4 earnings on Feb. 7. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Athenahealth's revenues will expand 26.7% and EPS will grow 16.7%.
The average estimate for revenue is $117.2 million. On the bottom line, the average EPS estimate is $0.28.
Last quarter, Athenahealth chalked up revenue of $105.9 million. GAAP reported sales were 26% higher than the prior-year quarter's $83.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.30. GAAP EPS of $0.17 for Q3 were 13% higher than the prior-year quarter's $0.15 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 60.5%, 170 basis points worse than the prior-year quarter. Operating margin was 7.0%, 330 basis points worse than the prior-year quarter. Net margin was 5.9%, 40 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $423.0 million. The average EPS estimate is $0.99.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 190 members out of 240 rating the stock outperform, and 50 members rating it underperform. Among 69 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 55 give Athenahealth a green thumbs-up, and 14 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Athenahealth is hold, with an average price target of $87.79.
Is Athenahealth the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Athenahealth to My Watchlist.